Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBOCICLIB vs RIFAMPICIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIBOCICLIB vs RIFAMPICIN: Safety Overview

Metric RIBOCICLIB RIFAMPICIN
Total FAERS Reports 27,997 179
Deaths Reported 4,501 34
Death Rate 16.1% 19.0%
Hospitalizations 6,700 79
Average Patient Age 60.2 yrs 46.8 yrs
% Female Patients 99.0% N/A
FDA Approval Date Mar 13, 2017 N/A
Manufacturer Novartis Pharmaceuticals Corporation N/A
Route ORAL N/A
Marketing Status Prescription N/A